Triphenylphosphine Oxide

Triphenylphosphine Oxide

SCHEMBL5835301

F.O=P(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 1/20 0.55
▸ CA4 P22748 1/20 0.55
▸ CA5A P35218 1/20 0.55
▸ LMNA P02545 1/20 0.54
▸ CFTR P13569 1/20 0.48
▸ ALDH1A1 P00352 4/20 0.46
▸ GAA P10253 2/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ ALPG P10696 1/20 0.46
▸ ALOX12 P18054 1/20 0.46
▸ NPY1R P25929 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ NPY2R P49146 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ ALOX15 P16050 1/20 0.44
▸ TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Triphenylphosphine Oxide SCHEMBL513223 0.97 CA2 (0.58) CA2CA4CA5ALMNACFTR
Triphenylphosphine Oxide SCHEMBL3949 0.97 CA2 (0.58) CA2CA4CA5ALMNACFTR
Triphenylphosphine Oxide SCHEMBL3753871 0.93 CA2 (0.55) CA2CA4CA5ALMNACFTR
Triphenylphosphine Oxide SCHEMBL14471889 0.93 CA2 (0.55) CA2CA4CA5ALMNACFTR
SCHEMBL5439069 0.93 LMNA (0.60) CA2CA4CA5ALMNACFTR
Triphenylphosphine Oxide SCHEMBL8431247 0.93 CA2 (0.63) CA2CA4CA5ALMNACFTR
SCHEMBL5436616 0.93 LMNA (0.60) CA2CA4CA5ALMNACFTR
Triphenylphosphine Oxide SCHEMBL15533922 0.93 CA2 (0.55) CA2CA4CA5ALMNACFTR
Triphenylphosphine Oxide SCHEMBL11214761 0.93 CA2 (0.55) CA2CA4CA5ALMNACFTR
Triphenylphosphine Oxide SCHEMBL3998427 0.93 CA2 (0.55) CA2CA4CA5ALMNACFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7090931-B2 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes E.I. DU PONT DE NEMOURS AND COMPANY (US) 2006-08-15 — — US disclosed
US-7087323-B2 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes E. I. DU PONT DE NEMOURS AND COMPANY (US) 2006-08-08 — — US disclosed
US-7074504-B2 Photoactive lanthanide complexes with phosphine oxides, phosphine oxides-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes E. I. DU PONT DE NEMOURS AND COMPANY (US) 2006-07-11 — — US disclosed
US-7074505-B2 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes E. I. DU PONT DE NEMOURS AND COMPANY (US) 2006-07-11 — — US disclosed
US-7063903-B2 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes E. I. DU PONT DE NEMOURS AND COMPANY (US) 2006-06-20 — — US disclosed
US-20050153165-A1 Photoactive lanthanide complexes with phosphine oxides, phosphine oxides-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes GRUSHIN VLADIMIR (US) 2005-07-14 — — US disclosed
US-20050106109-A1 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes GRUSHIN VLADIMIR (US) 2005-05-19 — — US disclosed
US-20050100511-A1 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes GRUSHIN VLADIMIR (US) 2005-05-12 — — US disclosed
US-20050095204-A1 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes GRUSHIN VLADIMIR (US) 2005-05-05 — — US disclosed
US-20050095202-A1 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes GRUSHIN VLADIMIR (US) 2005-05-05 — — US disclosed
US-20050095203-A1 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes GRUSHIN VLADIMIR (US) 2005-05-05 — — US disclosed
US-6875523-B2 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes E. I. DU PONT DE NEMOURS AND COMPANY (US) 2005-04-05 — — US disclosed
EP-1465595-A2 PHOTOACTIVE LANTHANIDE COMPLEXES WITH PHOSPHINE OXIDES, PHOSPHINE OXIDE-SULFIDES, PYRIDINE N-OXIDES, AND PHOSPHINE OXIDE-PYRIDINE N-OXIDES, AND DEVICES MADE WITH SUCH COMPLEXES E.I. DU PONT DE NEMOURS & COMPANY INCORPORATED (US) 2004-10-13 — — EP disclosed
WO-2003091688-A2 PHOTOACTIVE LANTHANIDE COMPLEXES WITH PHOSPHINE OXIDES, PHOSPHINE OXIDE-SULFIDES, PYRIDINE N-OXIDES, AND PHOSPHINE OXIDE-PYRIDINE N-OXIDES, AND DEVICES MADE WITH SUCH COMPLEXES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2003-11-06 — — WO disclosed
US-20030144487-A1 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes E. I. DU PONT DE NEMOURS AND COMPANY 2003-07-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050100511-A1 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes PNPO, PPOX, PDXK CA2 2031/4885CA4 1624/4885CA5A 1289/4885
US-20050095204-A1 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes PNPO, PPOX, PDXK CA2 2031/4885CA4 1624/4885CA5A 1289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback